医学
食管鳞状细胞癌
内科学
肿瘤科
新辅助治疗
放化疗
化疗
基底细胞
免疫疗法
癌
癌症
乳腺癌
作者
Yongkui Yu,Fanyu Meng,Xiufeng Wei,Xiankai Chen,Haomiao Li,Qi Liu,Can-jun Li,Hounai Xie,Lei Xu,Rui‐xiang Zhang,Wenqun Xing,Yin Li
标识
DOI:10.1016/j.jtcvs.2023.12.030
摘要
To date, few studies have compared effectiveness and survival rates of neoadjuvant chemotherapy combined with immunotherapy (NACI) and conventional neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). The present study was conducted to compare therapeutic response and survival between NACI and NCRT.
科研通智能强力驱动
Strongly Powered by AbleSci AI